Crisis management by HIV/AIDS non-governmental organisations in the post-Euromaidan Ukraine led to opening new horizons (Publications)
Public Health, one of the principal recipients of the Global Fund to Fight Tuberculosis, AIDS and Malaria in 2014-2016, during and after the Euromaidan Revolution in Ukraine. Findings In the post-Euromaidan
A major role for the <em>Plasmodium falciparum</em> ApiAP2 protein PfSIP2 in chromosome end biology (Publications)
framework for antigenic variation and evolution of subtelomeric virulence gene families in the malaria parasite Plasmodium falciparum. While recent studies assigned important roles for reversible histone
Feasibility and clinical outcomes when using practice guidelines for evaluation of fever in returning travelers and migrants: a validation study (Publications)
adherence rate was 54.8%. The main reasons for non-adherence were as follows: no repetition of malaria tests (111/352) and no presumptive antibiotic treatment for febrile diarrhea (64/153) or abdominal
Causes of acute undifferentiated fever and the utility of biomarkers in Chiangrai, northern Thailand (Publications)
continue to contribute substantially to the febrile disease burden throughout Southeast Asia while malaria is declining. Recently, there has been increasing focus on biomarkers (i.e. C-reactive protein (CRP)
Validation of <em>Plasmodium falciparum</em> dUTPase as the target of 5'-tritylated deoxyuridine analogues with anti-malarial activity (Publications)
BACKGROUND: Malaria remains as a major global problem, being one of the infectious diseases that engender highest mortality across the world. Due to the appearance of resistance and the lack of an effective
Nicolaus Lorenz: Dedicated to Improving People's Health (Page)
https://www.swisstph.ch/fr/news/20160601-nicolaus-lorenz-dedicated-to-improving-peoples-health
mandates; the most recent example being the investment framework for malaria eradication 2016–2030 (Action and Investment for Malaria Eradication – AIM) that was successfully launched in autumn 2015 and
Clinical Operations | A Trusted Partner in Clinical Trial Services (Page)
https://www.swisstph.ch/fr/about/med/clinical-operations
a privilege to be able to bring science to the bedside” – Elisabeth Reus on the launch of a new malaria clinical trial in the DRC Our Team - 11 Nationalities, 150 Years of Combined Expertise We are a global [...] Dis . 2023;23(4):463-470. DOI: 10.1016/S1473-3099(22)00660-0 Related Topics Infectious Diseases Malaria Human African Trypanosomiasis (HAT) Tuberculosis Related Activities Clinical Trials Organisational
Global Health in the 21st Century (Page)
https://www.swisstph.ch/fr/about/events/symposium-2021
Roll Back Malaria Working Group on Scalable Malaria Vector Control, the Scientific Advisory Committee for the INDEPTH Network of Demographic and Health Observatories, the WHO African Malaria Expert Committee [...] implementation of the National Malaria Control Programme in Tanzania. Professor Lengeler’s group is currently working to understand and improve access to malaria treatment in malaria-endemic countries, including [...] control of tropical diseases, with a strong focus on malaria. He has...
2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage <em>Plasmodium</em> infections (Publications)
acid biosynthesis pathway (PfFAS-II) has recently been shown to be indispensable for liver stage malaria parasites, the inhibitory potential of the HDAs against multiple P. falciparum FAS-II (PfFAS-II)
Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus... (Publications)
artemisinin resistance. Each model simulates 100 000 individuals in a particular transmission setting (malaria prevalence of 1%, 5%, 10%, or 20%) with a daily time step that updates individuals' infection status